Several inhibitors of the PI3K/Akt/mTOR axis were developed and tested in ALL patients [104]; nevertheless, only few of those drugs have been evaluated in childhood ALL patients [105]. The gene discussed is PIK3CD; the disease is acute lymphoblastic leukemia.